Skip to content

Latest filings

Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.

DateCompanyInsiderTransactionSharesPriceValueHoldings afterFiled
Mar 28, 2025FUL
FULLER H B CO
Campe Heather
Sr. VP, International Growth
AGrant or award
Phantom Unitsderivative
+40$54.77$2,1684,453Mar 31, 2025
Mar 27, 2025CIEN
CIENA CORP
GALLAGHER PATRICK
director
AGrant or award
Common Stock
+3,738$0.00$061,802Mar 31, 2025
Mar 31, 2025NG
NOVAGOLD RESOURCES INC
ADAMEK PETER
Vice President & CFO
AGrant or award
Common Shares
+2,364$3.25$7,6836,139Mar 31, 2025
Mar 27, 2025LGMK
LogicMark, Inc.
Archer Mark
Chief Financial Officer
AGrant or award
Series A Common Stock Purchase Warrantderivative
+67,794$0.13$8,47484,742Mar 31, 2025
Mar 27, 2025IPM
INTELLIGENT PROTECTION MANAGEMENT CORP.
Abada Yoram
director
AGrant or award
Stock Option (Right to Buy)derivative
+10,000$0.00$010,000Mar 31, 2025
Mar 27, 2025CIEN
CIENA CORP
PUMA MARY G
director
AGrant or award
Common Stock
+3,738$0.00$010,872Mar 31, 2025
Mar 27, 2025CIEN
CIENA CORP
AHMED HASSAN
director
AGrant or award
Common Stock
+3,738$0.00$023,420Mar 31, 2025
Mar 31, 2025CBU
COMMUNITY FINANCIAL SYSTEM, INC.
Fesette Neil E.
director
AGrant or award
Phantom Stock (Deferred Compensation)derivative
+203$56.75$12k6,903Mar 31, 2025
Mar 31, 2025CBU
COMMUNITY FINANCIAL SYSTEM, INC.
Singh Savneet
director
AGrant or award
Deferred Stock (Deferred Compensation)derivative
+308$56.75$18k308Mar 31, 2025
Mar 31, 2025AIR
AAR CORP
Widhani Hema
director
AGrant or award
Phantom Stockderivative
+391$0.00$0391Mar 31, 2025
Mar 27, 2025LH
LABCORP HOLDINGS INC.
BERBERIAN LANCE
EVP, Special Advisor, Strategy
AGrant or award
Common Stock
+3,325$0.00$020,005Mar 31, 2025
Mar 27, 2025APRE
Aprea Therapeutics, Inc.
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
AGrant or award
Common Stock
+3,365$0.00$022,733Mar 31, 2025
Mar 27, 2025APRE
Aprea Therapeutics, Inc.
Hamill John P.
SrVP/CFO/Prin Fin & Acct Ofcr
AGrant or award
Stock Options (Right to Buy)derivative
+13,460$0.00$013,460Mar 31, 2025
Mar 27, 2025APRE
Aprea Therapeutics, Inc.
Gilad Oren
President/CEO
AGrant or award
Common Stock
+6,725$0.00$0340,120Mar 31, 2025
Mar 27, 2025APRE
Aprea Therapeutics, Inc.
Gilad Oren
President/CEO
AGrant or award
Stock Options (Right to Buy)derivative
+26,900$0.00$026,900Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Andre Werner
Chief Financial Officer
AGrant or award
Class B Common Stock
+161$0.00$0350,835Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Trimback Thomas F
Chief Accounting Officer
AGrant or award
Class B Common Stock
+18$0.00$014,583Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Shaman David R.
Chief Legal Officer
AGrant or award
Class B Common Stock
+557$0.00$0699,959Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Moutte Julien
Chief Technology Officer
AGrant or award
Class B Common Stock
+85$0.00$052,584Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Lee James K
Chief Operating Officer
AGrant or award
Class B Common Stock
+308$0.00$0177,841Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Griswold Kirk B.
director
AGrant or award
Class B Common Stock
+91$0.00$0456,791Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Cumins Nicholas
Chief Executive Officer
AGrant or award
Class B Common Stock
+497$0.00$0440,169Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Bentley Raymond B.
director, owner
AGrant or award
Class B Common Stock
+1,754$0.00$016,345,982Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Bentley Keith A.
director, owner
AGrant or award
Class B Common Stock
+1,302$0.00$04,008,257Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
BENTLEY GREGORY S
Executive Chair & President
AGrant or award
Class B Common Stock
+4,050$0.00$07,758,279Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Bentley Barry J.
director, owner
AGrant or award
Class B Common Stock
+5$0.00$011,948,245Mar 31, 2025
Mar 27, 2025BSY
BENTLEY SYSTEMS INC
Ballard Brock
Chief Revenue Officer
AGrant or award
Class B Common Stock
+82$0.00$080,704Mar 31, 2025
Mar 27, 2025CIEN
CIENA CORP
FITT LAWTON W
director
AGrant or award
Common Stock
+3,738$0.00$0127,581Mar 31, 2025
Mar 27, 2025CIEN
CIENA CORP
FITT LAWTON W
director
AGrant or award
Common Stock
+1,590$0.00$0129,171Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Cantor Eric
Vice Chairman, MD
AGrant or award
2020 Incentive RSUsderivative
+77$0.00$07,182Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Cantor Eric
Vice Chairman, MD
AGrant or award
2021 Incentive RSUsderivative
+146$0.00$013,545Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Cantor Eric
Vice Chairman, MD
AGrant or award
2022 Incentive RSUsderivative
+275$0.00$025,482Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Cantor Eric
Vice Chairman, MD
AGrant or award
2023 Incentive RSUsderivative
+282$0.00$026,137Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Cantor Eric
Vice Chairman, MD
AGrant or award
2024 Incentive RSUsderivative
+167$0.00$015,469Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Cantor Eric
Vice Chairman, MD
AGrant or award
2024 Long Term Incentive RSUsderivative
+69$0.00$06,444Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Callesano Christopher
Chief Financial Officer
AGrant or award
2020 Incentive RSUsderivative
+5$0.00$0431Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Callesano Christopher
Chief Financial Officer
AGrant or award
2021 Incentive RSUsderivative
+8$0.00$0745Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Callesano Christopher
Chief Financial Officer
AGrant or award
2022 Incentive RSUsderivative
+19$0.00$01,762Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Callesano Christopher
Chief Financial Officer
AGrant or award
2023 Incentive RSUsderivative
+17$0.00$01,614Mar 31, 2025
Mar 27, 2025MC
Moelis & Co
Callesano Christopher
Chief Financial Officer
AGrant or award
2024 Incentive RSUsderivative
+17$0.00$01,610Mar 31, 2025
Mar 27, 2025DBVT
DBV Technologies S.A.
BAKER BROS. ADVISORS LP
director, owner
AGrant or award
First Pre-Funded Warrantderivativeindirect: See Footnotes
+2,299,656--2,299,656Mar 31, 2025
Mar 27, 2025DBVT
DBV Technologies S.A.
BAKER BROS. ADVISORS LP
director, owner
AGrant or award
First Pre-Funded Warrantderivativeindirect: See Footnotes
+25,005,240--25,005,240Mar 31, 2025
Mar 27, 2025DBVT
DBV Technologies S.A.
BAKER BROS. ADVISORS LP
director, owner
AGrant or award
BS Warrantderivativeindirect: See Footnotes
+2,299,656--2,299,656Mar 31, 2025
Mar 27, 2025DBVT
DBV Technologies S.A.
BAKER BROS. ADVISORS LP
director, owner
AGrant or award
BS Warrantderivativeindirect: See Footnotes
+25,005,240--25,005,240Mar 31, 2025
Mar 31, 2025EXEL
EXELIXIS, INC.
Aftab Dana
CSO/EVP Disc & Trans Research
AGrant or award
Common Stock
+132,819$0.00$0693,936Mar 31, 2025
Mar 27, 2025CIEN
CIENA CORP
NEVENS THOMAS MICHAEL
director
AGrant or award
Common Stock
+3,738$0.00$023,746Mar 31, 2025
Mar 28, 2025TCBK
TRICO BANCSHARES /
BAILEY DANIEL K
EVP Chief Banking Officer
AGrant or award
Restricted Stock Unitderivative
+3,684$0.00$011,636Mar 31, 2025
Mar 28, 2025TCBK
TRICO BANCSHARES /
BAILEY DANIEL K
EVP Chief Banking Officer
AGrant or award
Performance Stock Unitderivative
+3,684$0.00$015,374Mar 31, 2025
Mar 28, 2025TCBK
TRICO BANCSHARES /
CARNEY CRAIG B
EVP Chief Credit Officer
AGrant or award
Restricted Stock Unitderivative
+3,517$0.00$011,129Mar 31, 2025
Mar 28, 2025TCBK
TRICO BANCSHARES /
CARNEY CRAIG B
EVP Chief Credit Officer
AGrant or award
Performance Stock Unitderivative
+3,517$0.00$014,639Mar 31, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.